JP Morgan Chase’s NCI, Inc. NCIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,609
Closed -$115K 5439
2017
Q1
$115K Sell
7,609
-4,741
-38% -$66.6K ﹤0.01% 4272
2016
Q4
$172K Buy
12,350
+12,122
+5,317% +$153K ﹤0.01% 4230
2016
Q3
$3K Buy
+228
New +$2.85K ﹤0.01% 4419
2016
Q2
Sell
-9,778
Closed -$137K 5132
2016
Q1
$137K Buy
+9,778
New +$133K ﹤0.01% 3691

Other funds holding NCIT

JP Morgan Chase's NCIT Position: Q2 2017 in Review

JP Morgan Chase sold out of NCI, Inc. (NCIT) in Q2 2017, closing a stake of 7,609 shares — an estimated $115K sold.

JP Morgan Chase first reported a position in NCIT in Q1 2016 and held it in 4 quarters. The position peaked at $172K in Q4 2016. 71 funds tracked by Wall St. Rank hold NCIT as of Q2 2017.

  • JP Morgan Chase reported no remaining NCI, Inc. position as of Q2 2017 after selling out during the quarter.
  • JP Morgan Chase sold 7,609 NCI, Inc. shares in Q2 2017, an estimated $115K.
  • JP Morgan Chase first reported a position in NCI, Inc. in Q1 2016 and held it in 4 quarters.
  • JP Morgan Chase's NCI, Inc. position peaked at $172K in Q4 2016.
  • 71 funds tracked by Wall St. Rank held NCI, Inc. as of Q2 2017.

Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.